Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Antioxidants (Basel, Switzerland)|April 14, 2025
How Effectively Can Oxidative Stress and Inflammation Be Reversed When CFTR Function Is Pharmacologically Improved?Valeria Rachela Villella, Alice Castaldo, Filippo Scialò, et al.
BMC Pulmonary Medicine|September 9, 2024
Clinical features and outcomes of persons with cystic fibrosis and nocardia isolation: a systematic reviewVito Terlizzi, Tommaso Ballerini, Alice Castaldo, et al.
Journal of Translational Medicine|January 22, 2025
Serum HDL and their subfractions are impaired in multisystem inflammatory syndrome in children (MIS-C)Antonietta Giannattasio, Alice Castaldo, Michela Grieco, et al.
International Journal of Molecular Sciences|July 29, 2025
Pulmonary Function Modulates Epigenetic Age in Subjects with Cystic FibrosisAlice Castaldo, Mariella Cuomo, Paola Iacotucci, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 22, 2025
The treatment with Elexacaftor/Tezacaftor/Ivacaftor significantly increases serum bilirubin and decreases blood platelets in children and adolescents with cystic fibrosis homozygous or double heterozygous for the F508del CFTR variantAlice Castaldo, Chiara Cimbalo, Cristina Fevola, et al.
Journal of Clinical Medicine|July 29, 2025
Hemoglobin Levels in Children Treated for Cystic Fibrosis with CFTR Modulators: A Single Center Retrospective StudyAntonella Tosco, Raffaele Cerchione, Monica Gelzo, et al.
Scientific Reports|January 12, 2023
Lipidomic alterations in human saliva from cystic fibrosis patientsMarianna Caterino, Roberta Fedele, Vincenzo Carnovale, et al.
Diagnostics (Basel, Switzerland)|November 11, 2020
Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic FibrosisMonica Gelzo, Paola Iacotucci, Vincenzo Carnovale, et al.
Pageof 4